Additional information
Yellow Powder
168329-48-4
ACI-020805
280.1-282.3°C
C9H8BrN5
266.1
Ambient
2-8°C
ocular hypertension
Pharmaceutical Impurity Standards
1-(5-bromoquinoxalin-6-yl)guanidine
2-(5-Bromoquinoxalin-6-yl)guanidine
N-(5-Bromo-6-quinoxalinyl)quanidine





![TOFACITINIB DIMER (25 mg) (1,3-Bis{(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-1-piperidinyl}-1,3-propanedione)](https://analyticachemie.in/wp-content/uploads/uspimage-1.jpg)